Bio-Thera Solutions Ltd (688177) - Total Liabilities

Latest as of March 2026: CN¥2.16 Billion CNY ≈ $316.22 Million USD

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has total liabilities worth CN¥2.16 Billion CNY (≈ $316.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Bio-Thera Solutions Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Bio-Thera Solutions Ltd - Total Liabilities Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688177 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Bio-Thera Solutions Ltd Competitors by Total Liabilities

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
New Pacific Metals Corp TO:NUAG	Canada	CA$1.06 Million
Zug Estates Holding AG SW:ZUGN	Switzerland	CHF817.37 Million
Total Gabon F:RZW	Germany	€1.30 Billion
Shenzhen JingQuanHua Electronics Co Ltd SHE:002885	China	CN¥1.58 Billion
Green Plains Renewable Energy Inc NASDAQ:GPRE	USA	$795.73 Million
L&C Bio Co. Ltd KQ:290650	Korea	₩231.24 Billion
Tekla Healthcare Investors NYSE:HQH	USA	$3.43 Million
Yixin Group Limited F:1YX	Germany	€37.41 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Bio-Thera Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Bio-Thera Solutions Ltd market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	9.64	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.91	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Bio-Thera Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual total liabilities of Bio-Thera Solutions Ltd from 2016 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥1.91 Billion ≈ $279.68 Million	+27.64%
2024-12-31	CN¥1.50 Billion ≈ $219.12 Million	+39.38%
2023-12-31	CN¥1.07 Billion ≈ $157.22 Million	+87.67%
2022-12-31	CN¥572.48 Million ≈ $83.77 Million	+7.96%
2021-12-31	CN¥530.27 Million ≈ $77.60 Million	+36.82%
2020-12-31	CN¥387.56 Million ≈ $56.71 Million	+1.01%
2019-12-31	CN¥383.68 Million ≈ $56.15 Million	+74.85%
2018-12-31	CN¥219.44 Million ≈ $32.11 Million	-19.14%
2017-12-31	CN¥271.39 Million ≈ $39.71 Million	+56.10%
2016-12-31	CN¥173.86 Million ≈ $25.44 Million	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.06 Billion

CN¥7.28 Billion CNY

Market Cap Rank

#8645 Global

#2066 in China

Share Price

CN¥17.57

Change (1 day)

-1.84%

52-Week Range

CN¥16.10 - CN¥34.72

All Time High

CN¥71.90